Drug-induced diseases (DIDs): An experience of a tertiary care teaching hospital from India

Background & objectives: Drug-induced diseases (DIDs) are well known but least studied. Data on DIDs from India are not available. Hence, this retrospective cross-sectional study was undertaken using suspected adverse drug reaction (ADR) data collected form Pharmacovigilance Programme of India (PvPI) to evaluate profile of DIDs over two years, in a tertiary care teaching hospital from north India. Methods: The suspected ADRs in the form of DID were evaluated for drug and disease related variables and were classified in terms of causality. Results: DID rate was 38.80 per cent. Mean duration of developing DIDs was 26.05 ± 9.6 days; 25.16 per cent had more than one co-morbid condition. Geriatric population (53.99%) accounted for maximum DIDs followed by adult (37.79%) and paediatric (8.21%). Maximum events were probable (93.98%) followed by possible (6.04%). All DIDs required intervention. Gastritis (7.43%), diarrhoea (5.92%), anaemia (4.79%), hypotension (2.77%), hepatic dysfunction (2.69%), hypertension (1.51%), myalgia (1.05%), and renal dysfunction (1.01%) were some of the DIDs. Anti tubercular treatment (ATT), anti retroviral treatment (ART), ceftriaxone injection, steroids, non-steroidal anti-inflammatory drugs, antimicrobials and anticancer drugs were found as commonly offending drugs. Interpretation & conclusions: Our findings show that DIDs are a significant health problem in our country, which need more attention.

[1]  Sumbal Tariq,et al.  Frequency of anti-tuberculous therapy-induced hepatotoxicity in patients and their outcome. , 2009, Journal of Ayub Medical College, Abbottabad : JAMC.

[2]  T. V. D. van der Cammen,et al.  Contribution of adverse drug reactions to hospital admission of older patients. , 2000, Age and ageing.

[3]  F. Haramburu,et al.  [Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance]. , 1999, Therapie.

[4]  G. Garratty.  Drug-induced immune hemolytic anemia. , 2009, Hematology. American Society of Hematology. Education Program.

[5]  M. Mcmurdo,et al.  Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. , 1997, Age and ageing.

[6]  S. Comaish.  Drug-induced disease , 1968, The British journal of clinical practice.

[7]  M. Chowta,et al.  Evaluation of the adverse reactions of antiretroviral drug regimens in a tertiary care hospital , 2013, Indian journal of pharmacology.

[8]  Martin Mozina,et al.  The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty , 2009, BMC clinical pharmacology.

[9]  Diana Esaian,et al.  Drug-Induced Cardiovascular Adverse Events in the Intensive Care Unit , 2013, Critical care nursing quarterly.

[10]  J. George,et al.  Approach to the diagnosis and management of drug-induced immune thrombocytopenia. , 2013, Transfusion medicine reviews.

[11]  E. Hahn,et al.  Risk Factors Associated with Adverse Drug Reactions Following Hospital Admission , 2008, Drug safety.

[12]  M. Petrovic,et al.  DRUG INTERACTIONS AND ADVERSE DRUG REACTIONS IN THE OLDER PATIENTS ADMITTED TO THE EMERGENCY DEPARTMENT , 2013, Acta clinica Belgica.

[13]  X. Leverve,et al.  [Adverse drug effects observed at French admissions departments and emergency services (Prospective study of the National Educational Association for Teaching Therapeutics and proposals for preventive measures]. , 2003, Bulletin de l'Academie nationale de medecine.

[14]  S. Permpongkosol.  Iatrogenic disease in the elderly: risk factors, consequences, and prevention , 2011, Clinical interventions in aging.

[15]  Edward H. Lee.  American society of health-system pharmacists. , 2011, P & T : a peer-reviewed journal for formulary management.

[16]  A. Zwinderman,et al.  Prevalence of iatrogenic admissions to the Departments of Medicine/Cardiology/ Pulmonology in a 1,250 bed general hospital. , 2010, International journal of clinical pharmacology and therapeutics.

[17]  P. Saidón,et al.  Reacciones adversas medicamentosas y errores de prescripción: morbi-mortalidad , 2013 .

[18]  T. B. Vicedo,et al.  Adverse Drug Reactions Which Provoke Hospital Admission , 2011 .

[19]  L. Sahm,et al.  Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study , 2013, Emergency Medicine Journal.

[20]  R. Meyboom,et al.  Causality classification at pharmacovigilance centres in the european community , 1992 .

[21]  J. Reeves,et al.  Incidence and Costs of Adverse Drug Reactions in a Tertiary Care Pediatric Intensive Care Unit , 2013, Journal of clinical pharmacology.

[22]  M. Welsch,et al.  Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Centres régonaux de pharmacovigilance. , 1999 .

[23]  Frantz Thiessard,et al.  Trends in Spontaneous Adverse Drug Reaction Reports to the French Pharmacovigilance System (1986—2001) , 2005, Drug safety.

[24]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[25]  G. Garratty.  Immune hemolytic anemia associated with drug therapy. , 2010, Blood reviews.

[26]  Harvard Cw.  Drug-induced disease. , 1973 .

[27]  P. Noyce,et al.  Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.

[28]  N. Kshirsagar,et al.  HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India. , 2011, The International journal of risk & safety in medicine.

[29]  Susie H. Park,et al.  Liver injury associated with antidepressants. , 2013, Current drug safety.